Omnia Family Wealth’s Akari Therapeutics AKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $73.3K | Sell |
62,690
-24,938
| -28% | -$29.2K | 0.03% | 101 |
|
|
2025
Q1 | $109K | Hold |
87,628
| – | – | 0.05% | 90 |
|
|
2024
Q4 | $107K | Hold |
87,628
| – | – | 0.04% | 78 |
|
|
2024
Q3 | $259K | Hold |
87,628
| – | – | 0.11% | 69 |
|
|
2024
Q2 | $237K | Hold |
87,628
| – | – | 0.1% | 71 |
|
|
2024
Q1 | $163K | Hold |
87,628
| – | – | 0.08% | 73 |
|
|
2023
Q4 | $273K | Buy |
87,628
+28,511
| +48% | +$89K | 0.14% | 54 |
|
|
2023
Q3 | $234K | Buy |
59,117
+19,998
| +51% | +$79K | 0.14% | 57 |
|
|
2023
Q2 | $133K | Hold |
39,119
| – | – | 0.09% | 65 |
|
|
2023
Q1 | $142K | Hold |
39,119
| – | – | 0.11% | 65 |
|
|
2022
Q4 | $368K | Hold |
39,119
| – | – | 0.3% | 43 |
|
|
2022
Q3 | $493K | Buy |
39,119
+1,212
| +3% | +$15.3K | 0.41% | 28 |
|
|
2022
Q2 | $758K | Hold |
37,907
| – | – | 0.56% | 24 |
|
|
2022
Q1 | $910K | Buy |
37,907
+4,553
| +14% | +$109K | 0.6% | 23 |
|
|
2021
Q4 | $1M | Buy |
33,354
+10,000
| +43% | +$300K | 0.61% | 24 |
|
|
2021
Q3 | $761K | Hold |
23,354
| – | – | 0.52% | 29 |
|
|
2021
Q2 | $808K | Buy |
23,354
+2,525
| +12% | +$87.4K | 0.52% | 27 |
|
|
2021
Q1 | $1.1M | Buy |
20,829
+1,250
| +6% | +$66K | 0.82% | 21 |
|
|
2020
Q4 | $724K | Hold |
19,579
| – | – | 0.66% | 26 |
|
|
2020
Q3 | $681K | Hold |
19,579
| – | – | 0.65% | 28 |
|
|
2020
Q2 | $854K | Buy |
19,579
+10,366
| +113% | +$452K | 0.84% | 19 |
|
|
2020
Q1 | $267K | Buy |
9,213
+730
| +9% | +$21.2K | 0.28% | 56 |
|
|
2019
Q4 | $297K | Buy |
+8,483
| New | +$297K | 0.14% | 73 |
|